Copyright © 1996 by the European Society of Cardiology.
© 1996 The European Society of Cardiology
Increased levels of plasma thrombomodulin are associated with vascular and all-cause mortality in patients on long-term anticoagulant treatment

*Departrnent of Medicine, Skellefteå Hospital Umeå, Sweden
Department of Clinical Chemistry, Umeå University Hospital Umeå, Sweden
revised 6 February 1996; accepted 12 February 1996.
Dr J.-H. Jansson. Department of Medicine, Skellefteå Hospital, S-93186 Skellefteå Sweden
Abstract
BACKGROUND: The aim of the study was to test if plasma levels of thrombomodulin could predict mortality in 209 patients on long-term anticoagulant treatment followed up for 38 years.
METHODS AND RESULTS: The thrombomodulin level was 60·9 ± 29·8 µg. 11 for all 45 patients who died and 60·5 ± 30·5 .µg. 11 for the 38 vascular deaths, compared to 52·3 ± 20·7 µg. 11 for the 164 survivors. We found that, in Cox regression analyses, all-cause (P=0·025) and vascular mortality (P=0·042) was significantly and independently associated with increased levels of thrombomodulin.
CONCLUSIONS: The level of plasma thrombomodulin can predict all-cause and vascular mortality in patients on long-term anticoagulant treatment.
(Eur Heart J 1996; 17: 15031505)
Key Words: Anticoagulants vascular mortality risk factors thrombomodulin
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M. Lind, K. Boman, L. Johansson, T. K. Nilsson, A.-K. Ohlin, L. S. Birgander, and J.-H. Jansson Thrombomodulin as a Marker for Bleeding Complications During Warfarin Treatment Arch Intern Med, July 13, 2009; 169(13): 1210 - 1215. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-M. Olivot, J. Labreuche, M. Aiach, P. Amarenco, and for the GENIC Investigators Soluble Thrombomodulin and Brain Infarction: Case-Control and Prospective Study Stroke, August 1, 2004; 35(8): 1946 - 1951. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Oden and M. Fahlen Oral anticoagulation and risk of death: a medical record linkage study BMJ, November 9, 2002; 325(7372): 1073 - 1075. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. L. Li-Saw-Hee, A. D. Blann, and G. Y. H. Lip A cross-sectional and diurnal study of thrombogenesis among patients with chronic atrial fibrillation J. Am. Coll. Cardiol., June 1, 2000; 35(7): 1926 - 1931. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. F. Macko, L. A. Killewich, J. A. Fernandez, D. K. Cox, A. Gruber, and J. H. Griffin Brain-Specific Protein C Activation During Carotid Artery Occlusion in Humans Stroke, March 1, 1999; 30(3): 542 - 545. [Abstract] [Full Text] [PDF] |
||||
![]() |
M-C. Boffa and M. Karmochkine Review : Thrombomodulin: an overview and potential implications in vascular disorders Lupus, January 1, 1998; 7(2_suppl): S120 - S125. [Abstract] [PDF] |
||||
![]() |
J.-H. Jansson, K. Boman, M. Brannstrom, and T. K. Nilsson High Concentration of Thrombomodulin in Plasma Is Associated With Hemorrhage : A Prospective Study in Patients Receiving Long-term Anticoagulant Treatment Circulation, November 4, 1997; 96(9): 2938 - 2943. [Abstract] [Full Text] |
||||





